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Abstract
The effects of taurine on plasma and liver cholesterol, erythrocyte ouabain sensitive Na efflux and platelet aggregation were examined in Sprague
Dawley rats fed control or 0.5% cholesterol with 0.2% cholate diet. Plasma and liver levels of total cholesterol were increased significantly (p<0.05)
in rats fed cholesterol diet compared to the control, and taurine significantly decreased the elevated plasma level of cholesterol in rats fed cholesterol 
diet (p<0.05). HDL-cholesterol was decreased in groups fed the cholesterol diet regardless of taurine supplementation and the difference between
groups with and without cholesterol was significant (p<0.01). Plasma triglyceride was decreased and liver triglyceride was increased both significantly
(p<0.05) in rats fed cholesterol compared to the control. Plasma and liver triglyceride in rats fed taurine was decreased significantly compared to
the control (p<0.05).  Intracellular Na tended to be lower in rats fed cholesterol or taurine and higher in rats fed cholesterol plus taurine compared
to the control. Na efflux through Na-K ATPase and the passive leak of Na was somewhat reduced in rats fed cholesterol or taurine and was augmented
in rats fed cholesterol plus taurine compared to the control, which showed a similar trend to the intracellular Na. Taurine supplementation caused
a suppression of Na efflux in groups fed control diet and restored the suppressed Na efflux in groups fed cholesterol.   Platelet aggregation was
significantly decreased in the group fed taurine compared to the control (p<0.05) and the group fed cholesterol plus taurine was also a little lower 
in aggregation than the group fed cholesterol. Microscopic examination showed that taurine prevented fatty liver in rats fed cholesterol diet.  Taurine
known for stimulating Na-K ATPase in some cell types rather decreased erythrocyte ouabain sensitive Na-K ATPase in the present study. Taurine
had hypolipidemic and hypocholesterolemic effects and inhibited platelet aggregation which may be favorable for prevention of cardiovascular diseases.
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Introduction7)
Taurine (2-aminoethanesulfonic acid), a conditionally essential 
nutrient, is synthesized from amino acid cysteine or methionine 
and ubiquitously presented in animal tissues. High concentrations 
of taurine are found in heart, muscles, brain and eyes of 
mammals, and sea foods such as squids, clams, oysters are rich 
in taurine. Taurine has sulfur containing amino acid like structure 
and vitamin like biological functions such as heart rhythm, blood 
pressure, platelet aggregation, neural excitation, sperm motility, 
eye sight and bile acid synthesis (Huxtable, 1992). Taurine is 
known to be effective in protecting against cardiovascular 
diseases by affecting cholesterol metabolism, protecting blood 
vessels and blood cells from oxidative damages and controlling 
osmoregulation through membrane transport. Action mechanisms 
of taurine are not clear except its clearing action of cholesterol 
for bile acid synthesis in which taurine is used for conjugation 
to form the primary bile acid. Taurine, an organic osmolyte, 
regulates changes of cell volume and intracellular ion 
concentrations by controlling membrane ion permeability. 
Osmolarity-sensitive taurine efflux following cell swelling caused 
an increase in Na and K permeability and an anion channel 
blocker diminished this effect (Hall et al., 1996). Cellular 
accumulation of organic substances such as inositol, taurine and 
amino acids caused an opening of K and/or anion exit channels, 
and the extruded K
+ is pumped in by Na-K ATPase (Friedrich 
et al., 2006). Na-K ATPase acts on Na reabsorption in distal 
tubule and collecting duct of kidney cell. Na-K ATPase is 
reduced in patients with insulin resistant diabetes, obesity and 
hypertension (Hakam et al., 2006; Rabini et al., 1999). Angio-
tensin receptor agonists inhibit proximal tubule Na-K ATPase 
in obese hypertensive rat and Na induced hypertension was 
accelerated with taurine deficiency (Hakam et al., 2006). Platelet 
activating factor (PAF) released during certain pathological 
conditions such as ischemia may act on Na-K ATPase. PAF 
inhibited Na-K ATPase in rat cerebral cortex and these effects 
were abolished by a PAF antagonist. Stimulation of PAF receptor 
decreased Na-K ATPase in rat proximal tubule contributing to 
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Table 1. Composition of experimental diets (%)
Ingredient Control Taurine Cholesterol Cholesterol
+ Taurine
Casein
a)
L-methionine
a)
Lard
Soybean Oil
Choline 
chloride
b)
Vitamin mix
a)
Mineral mix
c)
Sucrose
Corn starch
Taurine
d)
Cholesterol
d)
Cholic acid
d)
20.0
0.3
9.0
1.0
0.2
1.0
3.5
20.0
45.0
-
-
-
20.0
0.3
9.0
1.0
0.2
1.0
3.5
20.0
40.0
5.0
-
-
20.0
0.3
9.0
1.0
0.2
1.0
3.5
20.0
44.3
-
0.5
0.2
20.0
0.3
9.0
1.0
0.2
1.0
3.5
20.0
39.3
5.0
0.5
0.2
Total (%) 100.0 100.0 100.0 100.0
a)  Harlan,  tekklad,  Madison  WI.
b)  Junsei  chemical,  Japan.
c)  Mixture  according  to  AIN 76A  (Mineral mixtuer(g/100g)  : CaHPO4  50.0, NaCl 
7.4,  K3C6H5O7․H2O  22.0,  K2SO4  5.2,  MgO  2.4,  Manganous 
carbonate(43-48%Mn) 0.35, Ferric citrate(16.7%Fe) 0.6, Zinc carbonate(70% Zn) 
0.16,  Cupric  carbonate(53-55%Cu)  0.03,  KIO3  0.001,  Na2SeO3․5H2O  0.001, 
CrK(SO4)2․12H2O  0.055,  Sucrose  11.804.
d)  Sigma  Chemicals,  Japan.
natriuresis (Handa et al., 2003). In in vitro study of platelet 
incubated with LDL, IDDM LDL significantly increased platelet 
aggregation and significantly reduced platelet membrane Na-K 
ATPase compared with control LDL (Rabini et al., 1999).
The purpose of this study was to examine the effect of taurine 
on CVD related three parameters using Sprague Dawley rats fed 
cholesterol diet. We measured plasma and liver levels of 
cholesterol, erythrocyte Na efflux through Na-K ATPase and Na 
passive leak and platelet aggregation using Sprague Dawley rats 
fed cholesterol diet.
Materials and Methods 
Animals and diets 
Forty of four weeks old Sprague Dawley rats (Orient Co Ltd, 
Gapyung, Korea) were divided into four groups  and fed ad 
libitum diets containing 0.5% cholesterol plus 0.2% cholate 
and/or 5% taurine along with the control diet for four weeks 
(Table 1). Rats had free access to water and were housed 
individual cages in a room maintained at 20-25℃ with a 12-hour 
dark-light cycle. Blood samples were obtained by cardiac 
puncture into heparinized vacuum tubes, and platelet aggregation 
and erythrocyte Na efflux were performed with fresh blood. Liver 
samples were prepared for microscopic examination and plasma 
and liver samples were stored at -70℃ for later assays. 
Plasma and liver lipid assays 
Liver lipids were extracted by a modified Folch method (Folch 
et al., 1957). One gram of liver tissue was homogenized in 6 
ml of Folch solution [chloroform(2):methanol(1)] and 2 ml H2O 
for 5 min and centrifuged. The lower phase contained liver lipids. 
Lower phase of lipid fractions after being treated with triton 
X-100:chloroform (25 µl:475 µl) for total cholesterol and meth-
anol for triglyceride was assayed using enzymatic kits (Asan 
Pharmaceuticals, Korea). 
Erythrocyte Na efflux 
Na efflux from erythrocyte occurs by at least three different 
pathways; Na-K ATPase,  Na-K cotransport and Na passive leak. 
Na-K ATPase can be defined as the ouabain sensitive Na efflux 
through the pump and can be measured from the difference of 
the efflux rates into MgCl2 medium with and without ouabain. 
Na leak is defined as the Na efflux through passive Na channel 
occurring under inhibition of ouabain sensitive Na-pump and 
furosemide sensitive Na
+-K
+ cotransport and can be measured 
from Na efflux into a choline chloride medium containing 
ouabain and furosemide (Garay et al., 1979; Smith et al., 1984).
Red cell preparation: Blood was centrifuged at 1,000 × g for 
10 minutes, and the plasma and buffy coat were removed. Red 
blood cells were washed 5 times with a cold isotonic washing 
solution [150 mM choline chloride, 10 mM Tris-4 morpholi-
nopropane sulfonic acid (MOPS), pH 7.4 at 4℃], centrifuging 
at 1,000 × g for 5 minutes after each wash. The RBC pellet was 
resuspended in the choline chloride washing solution to give 
40-50% hematocrit. The hematocrit was measured. A 50 µl 
aliquot of the RBC suspension was added to 5 ml of 0.025% 
acationox (a metal free detergent, Scientific Products, McGaw 
Park Illinois, USA) to be used for determination of intracellular 
Na concentrations. 
Na efflux: Four ml each of the RBC suspension were added 
to 40 ml MgCl2 medium with or without ouabain (70 mM MgCl2, 
10 mM KCl, 85 mM sucrose, 10 mM glucose, 10 mM Tris- 
MOPS, pH 7.4 at 37℃, 1 mM ouabain). Two ml of the RBC 
suspension was added to 40 ml of choline chloride medium (150 
mM choline chloride, 10 mM glucose, 1 mM ouabain, 1 mM 
furosemide, 10 mM   Tris-MOPS pH 7.4 at 37℃). The RBCs 
in each medium were mixed and aliquoted in each of 12 tubes. 
Tubes in duplicate were transferred to an ice bath after incubation 
in 37℃ shaking water bath for 0, 2, 4, 6, 8 and 10 min for 
Na efflux through the pump and 0, 10, 20, 30, 40 and 50 min 
for the passive leak of Na. Tubes were centrifuged at 1,000×g 
for 5 min, then the supernatant was removed and measured for 
Na concentration using Atomic Absorption Spectrophotometer 
(Shimadzu model AA6701F). 
Calculations (Kang & Smith, 1990);   
Na µg/(ml × min) × 60 min × mmole/23 mg × [44 ml-(4 ml × 
hct)/(0.0041 × hct)] × (mg/1000 µg)
=m m o l e / ℓ rbc/hour (Na efflux) 
Na µg/(ml × min) × mmole/23 mg × 101/hct × (mg/1000 µg) 
=m m o l e / ℓ rbc (intracelluar Na)202 Taurine on lipids, erythrocyte Na efflux and platelet aggregation
Table 2. Effects of taurine and cholesterol on weight gain and feed intake of
rats
Control Taurine Cholesterol Chol+Taurine
Final B.W (g) 399.46 ±36.4 360.88 ± 20.7 379.43 ± 34.5 399.57 ± 32.6
ADG (g/d)
1)* 8.16 ± 1.0 6.56 ± 1.2 7.49 ± 0.9 8.16 ± 1.0
ADFI (g/d)
2) 22.1 ± 1.9 21.1 ± 1.8 20.4 ± 2.1 23.17 ± 2.3
F.E.R
3)*  0.37 ± 0.03
a  0.31 ± 0.04
b  0.37 ± 0.03
a    0.35 ± 0.03
ab
L.W/B.W
4)  (%)** 2.87 ± 0.2
b 2.91 ± 0.5
b 5.12 ± 0.3
a 4.74 ± 0.4
a
1) A D G  :  A v e r a g e  d a i l y  g a i n .
2)  ADFI  :  Average  daily  feed  intake. 
3)  F.E.R  :  Feed  Efficiency  Ratio  (ADG/ADFI).  
4) L . W / B . W  :  L i v e r  w e i g h t  t o  f i n a l  b o d y  w e i g h t  r a t i o .
Values  are  means ± SD  of  10  rats. 
*  Values  in  the  same  row  not  sharing  the  same  superscript  differ  (p＜0.05).
** Values  in  the  same  row  not  sharing  the  same  superscript  differ  (p＜0.01). 
Table 3. Effects of taurine and cholesterol on Plasma and liver cholesterol and
triglyceride
 Control Taurine Cholesterol Chol+Taurine
Plasma
1)      
 Total-cholesterol* 100.5 ± 14.3
c 90.7 ± 10.5
c 227.3 ± 66.2
a 172.1 ± 26.2
b
 HDL-cholesterol* 22.4 ± 6.2
a 23.9 ± 6.8
a 16.3 ± 4.2
b 15.5 ± 4.3
b
 Triglyceride* 127.0 ± 33.6
a  70.8 ± 19.8
b  68.5 ± 11.5
b  54.1 ± 11.0
b
Liver
2)      
 Cholesterol* 5.53 ± 1.0
c 4.37 ± 1.2
c 43.62 ± 7.2
a 33.28 ± 6.6
ab
 Triglyceride* 16.8 ± 5.1
b 10.6 ± 3.7
bc  47.6 ± 16.9
a 43.0 ± 11.4
a
1) P la s m a  le v e l s  in  m g / 1 0 0  m l .
2)  Liver  levels  in  mg/g.
Values  are  means ± SD  of  10  rats.
*  V a l u e s  i n  t h e  s a m e  r o w  n o t  s h a r i n g  t h e  s a m e  s u p e r s c r ip t  d i f f e r  (p＜0.05).
** Values  in  the  same  row  not  sharing  the  same  superscript  differ  (p＜0.01).
Table 4. Effects of taurine and cholesterol on intracellular Na and erythrocyte 
Na efflux
 Control Taurine Cholesterol Chol+Taurine
Intracellular Na
1) 6.00 ± 1.87 5.58 ± 1.96 5.53 ± 1.16 7.03 ± 2.52
Na Efflux        
Na+-K+ ATPase
2) 2.91 ± 0.64 2.12 ± 0.73 2.33 ± 0.89 2.70 ± 0.62
Na Leak
3) 3.06 ± 0.81 2.29 ± 0.67 2.67 ± 0.80 2.80 ± 0.49
V a l u e s  a r e  m e a n s±S D  o f  1 0  r a t s . 
1) Intracellular Na ; upper values are for intact red blood cells. (Na mmole/ℓ rbc). 
2) N a
+-K
+  ATPase  is  ouabain  sensitive  Na  efflux  through  Na-pump. 
(Na  µmole/ml  rbc  /  hr).
3) Na leak is Na efflux through passive sodium  channel in intact red blood cells.
Platelet aggregation 
Platelet aggregation was measured using a Chronolog Whole 
Blood Aggregometor (model 500-Ca, Havertown, Pennsylvania, 
USA). The whole blood was diluted with isotonic saline (1:2) 
to give platelet concentration 400,000/µl. Adenosine diphoshate 
(ADP, 2 µM) was added to initiate aggregation, and three rea-
dings of impedance changes were averaged for each rat. Platelet 
aggregation caused an increase in impedance(Ω) across two 
platinum electrodes. The impedance method using the fresh 
whole blood has the advantage of measuring platelet aggregation 
under nearly physiological conditions in the presence of other 
blood components. 
Histological examination 
Two parts of liver samples each rat were obtained from 4 rats 
each group. After being washed with saline, samples were fixed 
in 10% formalin for 48 hours and dehydrated in xylene for 18 
hours. Samples were then embedded in paraffin and cut into 4-5 
um cross section. Tissues were stained with hematoxylin-eosin 
for microscopic observation. 
Statistical analysis 
Values were analyzed using the SAS package (version 8.02). 
Analysis of variance was conducted in a completely randomized 
block design. Duncan's multiple test was applied to compare 
individual means when F-value was significant (p<0.05). 
Results  
Weight gain, food efficiency and liver/body weight ratio 
Weight gain, food efficiency and liver/body weight ratio are 
listed in Table 2. Average daily gain (ADG) of taurine group 
was smallest among the groups with the lowest final weight, but 
not statistically different. Food efficiency ratio (FER, weight gain 
/food intake ratio) of taurine group was significantly decreased 
compared to other groups (p<0.05). Group fed taurine plus 
cholesterol recovered food intake and daily weight gain 
increasing the final weight to the control level. Liver/body weight 
ratio was significantly increased in groups of cholesterol and 
cholesterol plus taurine compared to the group of control or 
taurine (p<0.01). Taurine did not reduce the liver weight 
increased by feeding cholesterol diet. 
Plasma and liver cholesterol and triglyceride 
Plasma total cholesterol was significantly increased in groups 
fed cholesterol or cholesterol plus taurine compared to groups 
of control or taurine (p<0.05). Plasma total cholesterol of taurine 
group was lower than that of the control, but not significantly 
different (Table 3). However, the group fed cholesterol plus 
taurine had significantly lower plasma total cholesterol than the 
group fed cholesterol (p<0.05). Cholesterol lowering effect of 
taurine was more intensive in the cholesterol fed state. HDL- 
cholesterol was decreased in groups fed the cholesterol diet 
regardless of taurine supplementation and the difference between 
groups with or without cholesterol was significantly different 
(p<0.01). 
Erythrocyte Na efflux 
Intracellular Na tended to be lower in group fed cholesterol 
or taurine compared to the control group and higher in group 
fed cholesterol plus taurine compared to the control group (Table In Sun Park et al. 203
Table 5. Effects of taurine and cholesterol on platelet aggregation
 Control Taurine Cholesterol Chol+Taurine
Maximum (Ω)
1)*1 9 . 4 6 ± 3 . 2 0
a14.36 ± 1.85
b 17.13 ± 3.72
ab 14.20 ± 3.06
b
Initial Slope (Ω/min)
2)*1 7 . 4 3±2 .1 3
a13.04 ± 2.93
b 14.11 ± 3.37
ab 12.96 ± 2.59
b
1)  Maximum  aggregation  in  ohm  at  the  point  where  aggregation  dissociated. 
2) Initial slope is the base of one minute in tangent drawn to steepest part of curve. 
V a l u e s  a r e  m e a n s±S D  o f  1 0  r a t s . 
* Values  in  the  same  row  not  sharing  the  same  superscript  differ  (p＜0.05).
4). Na efflux through Na-K ATPase and Na passive leak was 
somewhat reduced in group fed cholesterol or taurine and was 
augmented in group fed cholesterol plus taurine compared to the 
control, which showed a similar trend to the intracellular Na. 
Taurine supplementation  caused a suppression of Na efflux in 
group fed control diet and restored the suppressed Na efflux in 
group fed cholesterol.   
Platelet aggregation 
As listed in Table 5, platelet aggregation was significantly 
decreased in the group fed taurine compared to the control 
(p<0.05) and the group fed cholesterol plus taurine was also 
lower in aggregation than the group fed cholesterol. Aggregation 
with high initial slope usually has high maximum aggregation 
as shown in the present study.  Aggregation with high initial slope 
also showed a sharp dissociation curve which may be associated 
with platelet age and survivability. 
Discussion 
Tufft et al. (1992) reported that dietary taurine did not affect 
weight gain but improved feed efficiency during the first week 
of the experiment in broiler cockerels. However, taurine 
decreased their overall feed efficiency. On the other hand, taurine 
depletion caused a significant growth depression before retinal 
degeneration in monkey (Hayes et al., 1980). Dietary taurine 
suppressed weight gain with reduced food intake in Wistar rats, 
but not in Sprague Dawley rats when they were fed high 
cholesterol diet (Yamamoto et al., 2000). In the present study, 
taurine deceased weight gain and food efficiency, but taurine 
with cholesterol recovered the reduced weight with increased 
food intake. Huxtable et al. (1976) suggested earlier that taurine 
might have a suppression effect on eating and drinking by 
specially depressing the area of hypothalamus for stimulating 
eating and drinking. Taurine reduced Ca dependent GABA 
release in mouse cerebral cortex and GABA is known to play 
a role as potent stimulus for feeding through orexin mechanism 
in appetite control (Burdakov et al., 2003; Kontro et al., 1987).
Hypocholestrolemic action of taurine can be speculated on the 
activation of cholesterol 7α-hydroxylase, suppression of HMG- 
CoA reductase, ileal bile acid reabsorption and perhaps LDL 
receptor. Taurine supplementation induced the gene expression 
of cholesterol 7α-hydroxylase in diabetic rats fed high chole-
sterol diet, enhancing cholesterol degradation (Mochizuki et al., 
1999). Murakami et al. (2002) reported that hepatic activity of 
cholesterol 7α-hydroxylase was doubled with taurine and taurine 
decreased cholesteryl ester contents, accompanied by decrease 
in acyl CoA:cholesterol acyltransferase (ACAT) activity. Tauro-
cholate is a potent down regulator of both HMG CoA reductase, 
the rate limiting enzyme for cholesterol synthesis, and cholesterol 
7α-hydroxylase, the rate limiting enzyme for bile acid synthesis 
(Pandak et al., 1992). Shefer et al. (1992) observed that chole-
sterol 7α-hydroxylase activity was increased with cholestyra-
mine and cholesterol feeding and decreased with taurocholate 
in rats. Both cholesterol and taurocholate administration sup-
pressed total microsomal HMG-CoA reductase activity by 87% 
and 65%, respectively. Taurocholate may be a far more potent 
inhibitor of cholesterol 7α-hydroxylase than other bile acids 
through feedback inhibition mechanism on bile acid synthesis 
(Shefer  et al., 1992). Up-regulation of the LDL receptor and 
subsequent increase in receptor-mediated LDL turnover can be 
another cholesterol-lowering event in hamsters fed taurine. 
(Murakami et al., 2002). Chen et al. (2004) observed that taurine 
did not affect LDL receptor protein level in C57BL/6 mice and 
the decrease in cholesterol in the circulation was mainly due to 
its suppressive effect on the concomitantly secreted TG from the 
liver. Cholesterol feeding caused a remarkable increase in liver 
triglyceride and total cholesterol (Chen et al., 2004; Liu et al., 
1995; Sobolova et al., 2006). Taurine supplementation resulted 
in markedly reduced hepatic secretion of cholesterol ester, 
preventing the hepatic accumulation of cholesterol in cholesterol 
fed rats (Chen et al., 2004). The present study showed that taurine 
supplementation caused decreased plasma and liver total 
cholesterol in both control and cholesterol fed groups. High 
cholesterol diet has been involved in increased total cholesterol 
and decreased HDL-cholesterol in different species (Oh et al., 
2002; Sobolová et al., 2006; Sorci-Thomas et al., 1989). Sorci- 
Thomas et al. (1989) suggested that accelerated apo A-1 clea-
rance from plasma may contribute to the reduction of HDL 
concentration resulting from cholesterol enriched diets. Cho-
lesterol diet resulted in the accumulation of liver triglyceride with 
decreased plasma triglyceride (Liu et al., 1995; Oh et al., 2002), 
which can be explained with increased de novo synthesis of liver 
triglyceride and decreased secretion of triglyceride to the blood 
(Liu et al., 1995). Hypolipidemic effect of taurine was far greater 
in rats fed control diet than those fed cholesterol diet. 
Cholesterol has been reported to be involved in membrane 
transport of cations. In vitro cholesterol enrichment of human 
erythrocyte caused an enzymatic inhibition of Na-K ATPase and 
decreased Na Efflux (Lijnen et al., 1995). Kurup et al. (2003) 
reported that plasma HMG CoA reductase activity was inversely 
correlated with erythrocyte membrane Na K ATPase in 
Alzheimer patients. Tranquilli et al. (2004) observed that higher 
cholesterol/phospholipid ratio was correlated with the reduced 
erythrocyte Na-K ATPase in pregnant women. Lower membrane 204 Taurine on lipids, erythrocyte Na efflux and platelet aggregation
Fig. 1. Microscopic appearance of liver tissue, (400)
fluidity with high plasma cholesterol/phospholipid ratio may be 
associated with lower Na-K ATPase which caused the progres-
sion of hypertension in pregnant women (Tranquilli et al., 2004). 
Mayol et al., (1999) reported that cholesterol enrichment signi-
ficantly reduced Na-K ATPase in cultured human endothelial 
cells. The present study showed that cholesterol supplementation 
reduced erythrocyte Na-K ATPase as in previous studies. Taurine 
in human erythrocyte activated ouabain sensitive Na-K ATPase 
in the presence of calcium (Igisu et al., 1976). Qi et al. (1995) 
reported that taurine restored the depleted erythrocyte membrane 
Na-K ATPase activity due to cholesterol enrichment in in vitro 
system. In the present study, taurine supplementation rather 
reduced erythrocyte Na-K ATPase, but taurine with cholesterol 
tended to increase Na-K ATPase. Mrsny et al. (1985) reported 
that taurine and hypotaurine reduced hamster sperm cell Na-K 
ATPase for sustaining sperm motility. Taurine on Na-K ATPase 
may function differently depending upon cell types and numerous 
methods such as phosphate production, substrate concentration 
and Na efflux can be used as parameters for Na-K ATPase 
activity. Na leak is Na passive transport driven by intracelluar 
concentration of Na. Na efflux through Na leak in the present 
study was matched with the intracellular Na. High intracellular 
Na may be associated with decreased Na-K ATPase activity, 
followed by increased intracellular fluid (Lijnen et al., 1995). 
Zicha et al. (2001) reported an opposing result that abnormally 
high erythrocyte Na-K ATPase was a consequence of elevated 
erythrocyte Na content and associated with abnormal cholesterol 
metabolism in Dahl salt sensitive rats. In the present study, high 
Na-K ATPase with high intracellular Na in control or taurine 
plus cholesterol is rather consistent with the results of Zicha. 
Taurine and β-alanine are known to be cotransported into cell 
with Na ions and then Na ions are pumped back out against 
concentration via Na-K ATPase. More studies should be done 
to clear the action mechanism of taurine and cholesterol on Na-K 
ATPase and intracellular volume. 
Platelet from hypercholesterolemic patient was more reactive 
to platelet activating factor (PAF) and the maximal aggregation 
was correlated with plasma PAF acetylhydrolase and total 
cholesterol (Elisaf et al., 1999). Platelet from hypercholeste-
rolemic rat was more sensitive to thrombin and showed higher 
aggregability, and thrombin generation in the 2nd phase of 
platelet aggregation was far higher in hypercholesterolemic rats 
than the control (Winocour et al., 1990). In the present study, 
platelet from cholesterol fed rats was less sensitive in ADP 
induced whole blood platelet aggregation compared to those from 
control rats. However, taurine caused decreased platelet aggre-
gation with or without cholesterol supplementation. Taurine has 
been considered as a modulator of platelet function. Taurine 
functions on platelet aggregation through PDGF-BB receptor 
dephosphorylation in vascular smooth muscle taurine, causing 
a significant suppression of PDGF-induced endothelial cell 
proliferation (Yoshimura, 2005). Taurine suppressed calcium 
induced platelet aggregation in vivo and ex vivo in vegetarians 
(McCarty, 2004). Taurine functions physiologically to dampen 
the calcium influx evoked by aggregating agonists, thereby 
down-regulating platelet aggregation. Platelet taurine causes a 
decrease in sensitivity of platelet to aggregating agonists such 
as thrombin, ADP, epinephrine, collagen and arachidonate.
Livers from rats fed control and taurine were both normal and 
not different on gross observation. However, livers from rats fed 
cholesterol and cholesterol plus taurine were much larger and 
hypochromic, defined as fatty liver. On microscopic observation 
(Fig. 1), liver specimens from cholesterol plus taurine showed 
less fat drops than those from rats fed cholesterol, which suggests 
that taurine can lessen fatty liver in some extent when animal 
is on the hypercholesterolemic diet.
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